Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,781,559
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
11,606,587
-
Shares change
-
+371,990
-
Total reported value, excl. options
-
$161,634,440
-
Value change
-
+$5,200,204
-
Number of buys
-
20
-
Number of sells
-
-16
-
Price
-
$13.93
Significant Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q3 2021
46 filings reported holding FHTX - Foghorn Therapeutics Inc. - COMMON STOCK as of Q3 2021.
Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,606,587 shares
of 55,781,559 outstanding shares and own 20.81% of the company stock.
Largest 10 shareholders include FMR LLC (2,520,134 shares), Artal Group S.A. (1,720,720 shares), Euclidean Capital LLC (1,261,261 shares), BlackRock Inc. (1,119,685 shares), MORGAN STANLEY (979,113 shares), VANGUARD GROUP INC (839,917 shares), Monashee Investment Management LLC (530,581 shares), Alphabet Inc. (500,901 shares), Birchview Capital, LP (314,143 shares), and GEODE CAPITAL MANAGEMENT, LLC (272,707 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.